Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Cancer Epidemiol. 2015 Jun 9;39(4):567–570. doi: 10.1016/j.canep.2015.05.003

Table 1.

Age-standardized Characteristics According to Measures of Baseline Body Fat Distribution* in 1986 in the Nurses’ Health Study

WC Categories (in) HC Categories (in) WHR Categories
Category cutoff ≤27 30–32 ≥38 ≤36 39-40 ≥45 ≤0.73 0.77–<0.81 ≥0.88
Number of subjects 7612 9101 2667 6890 7542 3050 8298 7312 2431
Age, yr 50.3 (7.0) 53.4 (7.1) 54.5 (7.0) 51.6 (7.4) 52.9 (7.3) 53.4 (7.0) 50.4 (7.0) 53.2 (7.1) 55.2 (7.1)
BMI, kg/m2 20.9 (1.9) 24.4 (2.6) 33.5 (5.2) 21.0 (2.2) 24.1 (2.4) 33.2 (4.9) 22.7 (3.3) 24.9 (4.4) 28.3 (5.3)
Smoking
Never, % 43 44 44 39 45 47 48 43 40
Past, % 33 35 38 31 36 38 34 34 34
Current, % 24 21 18 30 19 15 18 23 25
Pack years 12.0 (17.2) 12.4 (17.9) 13.9 (19.7) 14.8 (19.2) 11.7 (17.2) 11.7 (17.6) 9.7 (15.2) 12.9 (18.0) 15.9 (20.6)
Age at menarche, yr 12.7 (1.4) 12.6 (1.4) 12.3 (1.5) 12.7 (1.5) 12.6 (1.4) 12.3 (1.4) 12.6 (1.4) 12.6 (1.4) 12.5 (1.5)
Parity (no. of children) 2.7 (1.5) 3.0 (1.6) 3.1 (1.7) 2.8 (1.6) 3.0 (1.6) 3.1 (1.7) 2.8 (1.5) 3.0 (1.6) 3.1 (1.7)
Oral contraceptive use, % 49 47 43 48 48 44 49 47 45
Postmenopausal, % 55 55 57 56 55 56 55 56 56
Postmenopausal hormone use, % (among postmenopausal women only)
    No use 57 64 76 62 64 76 60 65 73
    Oral conjugated estrogen 15 12 8 14 12 8 14 12 9
    Oral estrogen & progesterone 11 9 4 9 9 4 10 8 4
    Others 17 15 12 16 15 11 16 15 14
*

WC, waist circumference; HC, hip circumference; WHR, waist-to-hip ratio. All data are presented as mean (standard deviation) unless otherwise specified. With the exception of age, all data shown are standardized to the age distributions of the cohort.